Authors:
DALIANI D
ULMER RA
JACKOW C
PUGH W
GANSBACHER B
CABANILLAS F
DUVIC M
SARRIS AH
Citation: D. Daliani et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10, Leukemia & lymphoma, 29(3-4), 1998, pp. 315
Citation: M. Duvic et al., DAB(389)IL2 DIPHTHERIA FUSION TOXIN PRODUCES CLINICAL-RESPONSES IN TUMOR STAGE CUTANEOUS T-CELL LYMPHOMA, American journal of hematology, 58(1), 1998, pp. 87-90
Citation: Nv. Konstantinova et al., NERVE GROWTH-FACTOR IN NORMAL AND PSORIATIC SKIN EQUIVALENT MODELS, Archives of dermatological research (Print), 290(11), 1998, pp. 610-614
Authors:
CATHER JC
FARMER A
JACKOW C
MANNING JT
SHIN DM
DUVIC M
Citation: Jc. Cather et al., UNUSUAL PRESENTATION OF MYCOSIS-FUNGOIDES AS PIGMENTED PURPURA WITH MALIGNANT THYMOMA, Journal of the American Academy of Dermatology, 39(5), 1998, pp. 858-863
Citation: M. Duvic et R. Marks, PRESENTED AT THE SYMPOSIUM, TAZAROTENE - OPTIMIZING THE THERAPEUTIC BENEFITS OF A NEW TOPICAL RECEPTOR-SELECTIVE RETINOID, SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM ALLERGAN, INC. - INTRODUCTION, Journal of the American Academy of Dermatology, 39(4), 1998, pp. 123-123
Citation: M. Duvic et al., THE PATHOGENESIS OF PSORIASIS AND THE MECHANISM OF ACTION OF TAZAROTENE, Journal of the American Academy of Dermatology, 39(4), 1998, pp. 129-133
Citation: Sr. Peterson et al., ANTINUCLEAR ANTIBODY SEROPOSITIVITY IN PATIENTS WITH CUTANEOUS T-CELLLYMPHOMA, Journal of the American Academy of Dermatology, 39(3), 1998, pp. 434-438
Authors:
JACKOW C
PUFFER N
HORDINSKY M
NELSON J
TARRAND J
DUVIC M
Citation: C. Jackow et al., ALOPECIA-AREATA AND CYTOMEGALOVIRUS-INFECTION IN TWINS - GENES VERSUSENVIRONMENT, Journal of the American Academy of Dermatology, 38(3), 1998, pp. 418-425
Authors:
CATHER JC
JACKOW C
YEGGE J
HAGEMEISTER F
DUVIC M
Citation: Jc. Cather et al., MYCOSIS-FUNGOIDES WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS AND NEPHROTIC SYNDROME, Journal of the American Academy of Dermatology, 38(2), 1998, pp. 301-305
Authors:
KONSTANTINOVA NV
LEMAK NA
DUONG DMT
CHUANG AZ
URSO R
DUVIC M
Citation: Nv. Konstantinova et al., ARTIFICIAL SKIN EQUIVALENT DIFFERENTIATION DEPENDS ON FIBROBLAST DONOR SITE - USE OF EYELID FIBROBLASTS, Plastic and reconstructive surgery, 101(2), 1998, pp. 385-391
Citation: P. Hazarika et al., EPIDERMAL SURFACE-ANTIGEN (ESA) IS DISTINCT FROM ECS-1 ANTIGEN AND CONFERS A DENDRITIC PHENOTYPE TO COS CELLS, Journal of investigative dermatology, 110(4), 1998, pp. 542-542
Citation: Ea. Olsen et al., PIVOTAL PHASE-III TRIAL OF 2 DOSE LEVELS OF DAB(389)IL-2 (ONTAK(TM)) FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL), Journal of investigative dermatology, 110(4), 1998, pp. 678-678
Authors:
YAN J
SHAO L
WALSH GM
OMURA GA
SALEH M
DUVIC M
LING M
DIASIO RB
Citation: J. Yan et al., INITIAL MULTIPLE-DOSE PHARMACOKINETICS OF ORAL-ADMINISTRATION OF BCX-34, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 97-97
Authors:
DIAMANDIDOU E
COLOMEGRIMMER M
FAYAD L
DUVIC M
KURZROCK R
Citation: E. Diamandidou et al., TRANSFORMATION OF MYCOSIS FUNGOIDES SEZARY-SYNDROME - CLINICAL CHARACTERISTICS AND PROGNOSIS/, Blood, 92(4), 1998, pp. 1150-1159
Authors:
SARRIS AH
DALIANI D
ULMER R
CROW M
BROXMEYER HE
REISS M
KARASAVVAS N
ZELENETZ AD
PUGH W
CABANILLAS F
DEISSEROTH AB
DUVIC M
Citation: Ah. Sarris et al., INTERFERON-INDUCIBLE PROTEIN-10 AS A POSSIBLE FACTOR IN THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS, Clinical cancer research, 3(2), 1997, pp. 169-177
Citation: Mm. Goller et al., LICHEN AMYLOIDOSIS PRESENTING AS A PAPULAR PRURITUS SYNDROME IN A HUMAN-IMMUNODEFICIENCY-VIRUS-INFECTED MAN, Dermatology, 194(1), 1997, pp. 62-64
Authors:
SARRIS AH
LUTHRA R
PAPADIMITRACOPOULOU V
WAASDORP M
DIMOPOULOS MA
MCBRIDE JA
CABANILLAS F
DUVIC M
DEISSEROTH A
MORRIS SW
PUGH WC
Citation: Ah. Sarris et al., LONG-RANGE AMPLIFICATION OF GENOMIC DNA DETECTS THE T(2-5)(P23-Q35) IN ANAPLASTIC LARGE-CELL LYMPHOMA, BUT NOT IN OTHER NON-HODGKINS-LYMPHOMAS, HODGKINS-DISEASE, OR LYMPHOMATOID PAPULOSIS, Annals of oncology, 8, 1997, pp. 59-63
Authors:
COHEN PR
ULMER R
THERIAULT A
LEIGH IM
DUVIC M
Citation: Pr. Cohen et al., EPIDERMOLYTIC ACANTHOMAS - CLINICAL CHARACTERISTICS AND IMMUNOHISTOCHEMICAL FEATURES, The American journal of dermatopathology, 19(3), 1997, pp. 232-241
Authors:
JACKOW CM
PAPADOPOULOS E
NELSON B
TSCHEN JA
HEATHERINGTON G
DUVIC M
Citation: Cm. Jackow et al., FOLLICULAR MUCINOSIS ASSOCIATED WITH SCARRING ALOPECIA, OLIGOCLONAL T-CELL RECEPTOR V-BETA EXPANSION, AND STAPHYLOCOCCUS-AUREUS - WHEN DOESFOLLICULAR MUCINOSIS BECOME MYCOSIS-FUNGOIDES, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 828-831
Citation: Pr. Cohen et al., LOCALIZED SCLERODERMA IN BREAST-CANCER PATIENTS TREATED WITH SUPERVOLTAGE EXTERNAL-BEAM RADIATION - RADIATION PORT SCLERODERMA - REPLY, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 807-808
Authors:
DUVIC M
NAGPAL S
ASANO AT
CHANDRARATNA RAS
Citation: M. Duvic et al., MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS, Journal of the American Academy of Dermatology, 37(2), 1997, pp. 18-24
Citation: M. Duvic, RESPONSE RATES IN PHOTOPHERESIS THERAPY FOR CUTANEOUS T-CELL LYMPHOMA- REPLY, Journal of the American Academy of Dermatology, 37(2), 1997, pp. 288-288
Authors:
WEINSTEIN GD
KRUEGER GG
LOWE NJ
DUVIC M
FRIEDMAN DJ
JEGASOTHY BV
JORIZZO JL
SHMUNES E
TSCHEN EH
LEWKAYA DA
LUE JC
SEFTON J
GIBSON JR
CHANDRARATNA RAS
Citation: Gd. Weinstein et al., TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT, Journal of the American Academy of Dermatology, 37(1), 1997, pp. 85-92
Authors:
BYERS PH
DUVIC M
ATKINSON M
ROBINOW M
SMITH LT
KRANE SM
GREALLY MT
LUDMAN M
MATALON R
PAUKER S
QUANBECK D
SCHWARZE U
Citation: Ph. Byers et al., EHLERS-DANLOS-SYNDROME TYPE VIIA AND VIIB RESULT FROM SPLICE-JUNCTIONMUTATIONS OR GENOMIC DELETIONS THAT INVOLVE EXON-6 IN THE COL1A1 AND COL1A2 GENES OF TYPE-I COLLAGEN, American journal of medical genetics, 72(1), 1997, pp. 94-105